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Introduction
Bullous systemic lupus erythematosus (BSLE) has rarely
been described in pediatric lupus population and to our
knowledge the prevalence of childhood BSLE has not
been reported.
Objectives
To evaluate the prevalence and describe cases of BSLE
in childhood-onset SLE (c-SLE) patients.
Methods
From 1983 to 2013, 303 c-SLE patients were followed
at the Pediatric Rheumatology Unit of the Children´s
Institute of Hospital das Clínicas da Faculdade de Med-
icina da Universidade de Sao Paulo. Three of them
(1%) presented BSLE and are described herein.
Results
Case 1
A 10-year old boy presented fever, arthritis and general-
ized tense vesicles and bullae on the face, oral mucosa and
trunk. Biopsy of a vesicle showed a subepidermal blister
with neutrophilic microabcesses in dermal papillae and
perivascular lymphocytes and neutrophils infiltration.
Direct immunofluorescence (DIF) revealed IgG/IgA/IgM
deposits at BMZ. After 1 month, he presented oral ulcers
and pleural effusion. Laboratory findings showed hemo-
globin 9.3g/dL, WBC 7,300/mm³(73%neutrophils, 21%
lymphocytes), platelets 398,000/mm³, C3 45mg/dL and C4
6mg/dL. Urinalysis showed leukocytes 1,000/ml and ery-
throcytes 21,000/mL. Immunological tests showed positive
ANA 1:640, anti-dsDNA, anti-Sm, anti-Ro/SSA and anti-
La/SSB autoantibodies. He fulfilled Camisa and Sharma
diagnostic criteria. At that moment the SLEDAI-2K score
was 18. He was treated with methylprednisolone pulse
therapy (30mg/kg/day for 3 days), followed by prednisone
(1.0mg/kg/day), hydroxychloroquine and dapsone. After
one month, the vesicles and bullous lesions improved
immensely.
Case 2
A 10-year-old girl presented recurrent bullae and vesicular
lesions on the trunk for two months. Two months later,
she presented oral ulcers, arthritis, pericarditis, and arterial
hypertension. A skin biopsy showed neutrophilic bullous
dermatitis with subepidermal cleavage. DIF revealed
deposits of IgG/IgM/IgA/C3 at the BMZ. Hemoglobin was
10.9g/dL, WBC 7,590/mm³ (87%neutrophils, 9%lympho-
cytes) and platelets 354,000/mm³, C3 38mg/dL and C4
3mg/dL. Proteinuria was 0.67g/day. Immunological tests
showed positive ANA 1:1280 and positive anti-ds DNA,
anti-Sm, anti-Ro/SSA autoantibodies. The renal biopsy
showed focal proliferative lupus nephritis. The SLEDAI-
2K score was 24. She was treated with methylprednisolone
pulse therapy, followed by prednisone, monthly intrave-
nous cyclophosphamide (500-1000mg/m2) and hydroxy-
chloroquine. After 4 months, she progressively improved,
with complete resolution of bullous lesions with residual
pigmentary changes.
Case 3
A 6 years girl, presented with fever and vesicles and bul-
lous lesions on the neck, lower limbs, and oral mucosa
for 2 months. Skin biopsy showed subepidermal blister
with neutrophil inflammation in the upper dermis and
DIF showed deposition of IgA, IgM and IgG. Two
months later, the patient developed eyelid edema and
oral ulcers. Hemoglobin was 7.9g/dL, ANA 1:200 and
positive anti-Sm and proteinuria was 0.6g/day. Renal
biopsy revealed mesangial proliferative lupus nephritis.
She received methylprednisolone pulses, prednisone,
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hydroxychloroquine and dapsone. After 4 months, she
presented progressive improvement of the bullous
lesions.
Conclusion
In the last 30 years, the prevalence of BSLE in childhood
was 1% in our tertiary University Hospital. Vesiculobullous
skin involvement was the first disease manifestation in all
three cases. A diagnosis of SLE should always be consid-
ered in children with recurrent tense vesiculobullous
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